Radiotherapy for Hepatocellular Carcinoma
Koichi Tokuuye, Shuichi Okada(National Cancer Center), Hideki Ueno(National Defense Medical College), Hiroshi Ikeda, Takuji Okusaka(National Cancer Centre Japan), Mitsuhiko Kawashima(National Cancer Center Hospital East), Yoshikazu Kagami(Tokyo National Hospital), Shigeyuki Murayama, Minako Sumi(Tokyo Metropolitan Geriatric Hospital)
Cited by 23
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749